FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

425981005: Aliskiren hemifumarate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2663055010 Aliskiren fumarate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2675070010 Aliskiren fumarate en Synonym Active Entire term case insensitive SNOMED CT core module
3761566015 Aliskiren hemifumarate en Synonym Active Entire term case insensitive SNOMED CT core module
1940051000001115 Aliskiren hemifumarate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aliskiren hemifumarate Is a Aliskiren false Inferred relationship Existential restriction modifier
Aliskiren hemifumarate Has disposition Renin inhibitor true Inferred relationship Existential restriction modifier
Aliskiren hemifumarate Is modification of Aliskiren true Inferred relationship Existential restriction modifier
Aliskiren hemifumarate Is a Substance with renin inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Aliskiren hemifumarate Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Aliskiren hemifumarate Is a Tetrazole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has basis of strength substance False Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has basis of strength substance False Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has precise active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 3
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 3
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 2
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 2
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier 2
Aliskiren 300mg tablets Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 150mg tablets Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (CST Pharma Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (CST Pharma Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 150mg tablets 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 300mg tablets 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) 30 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 150mg tablets Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Waymade Healthcare Plc) 30 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 150mg tablets 30 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 300mg tablets 30 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Aliskiren 300mg tablets Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Waymade Healthcare Plc) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Waymade Healthcare Plc) 28 tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Waymade Healthcare Plc) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 150mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start